These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1420648)

  • 1. Effect of 12-hour infusion of naloxone on mood and cognition in normal male volunteers.
    Martín del Campo AF; McMurray RG; Besser GM; Grossman A
    Biol Psychiatry; 1992 Aug; 32(4):344-53. PubMed ID: 1420648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of naloxone on diurnal rhythms in mood and endocrine function: a dose-response study in man.
    Martin del Campo AF; Dowson JH; Herbert J; Paykel ES
    Psychopharmacology (Berl); 1994 May; 114(4):583-90. PubMed ID: 7855219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of eight-hour naloxone infusions on human subjects.
    Grevert P; Albert LH; Inturrisi CE; Goldstein A
    Biol Psychiatry; 1983 Dec; 18(12):1375-92. PubMed ID: 6661468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid peptide and alpha-adrenoceptor pathways in the regulation of the pituitary-adrenal axis in man.
    Delitala G; Trainer PJ; Oliva O; Fanciulli G; Grossman AB
    J Endocrinol; 1994 Apr; 141(1):163-8. PubMed ID: 8031419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological challenge with naloxone and cue exposure in alcohol dependence: results of a randomized, double-blind placebo-controlled trial.
    Lieb M; Palm U; Chiang S; Laubender RP; Nothdurfter C; Sarubin N; Mokhtari-Nejad R; Koller G; Soyka M
    World J Biol Psychiatry; 2013 Sep; 14(7):539-46. PubMed ID: 24020866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis in normal man.
    Inder WJ; Ellis MJ; Evans MJ; Donald RA
    Clin Endocrinol (Oxf); 1995 Oct; 43(4):425-31. PubMed ID: 7586616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of the plasma concentration-effect relationship as a tool for the study of the mechanism of action of naloxone effects on mood and endocrine function.
    Martín del Campo AF; Granados-Soto V; Aguirre-Bañuelos P; Cárdenas M; Castañeda-Hernández G
    J Psychopharmacol; 1997; 11(4):361-5. PubMed ID: 9443526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of desipramine on basal and naloxone-stimulated cortisol secretion in humans: interaction of two drugs acting on noradrenergic control of adrenocorticotropin secretion.
    Torpy DJ; Grice JE; Hockings GI; Crosbie GV; Walters MM; Jackson RV
    J Clin Endocrinol Metab; 1995 Mar; 80(3):802-6. PubMed ID: 7883833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different opioid mechanisms are involved in the modulation of ACTH and gonadotrophin release in man.
    Grossman A; Moult PJ; Cunnah D; Besser M
    Neuroendocrinology; 1986; 42(4):357-60. PubMed ID: 3008020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin increases the human hypothalamic-pituitary-adrenal axis response to naloxone stimulation.
    Hockings GI; Grice JE; Crosbie GV; Walters MM; Jackson AJ; Jackson RV
    J Clin Endocrinol Metab; 1993 Aug; 77(2):404-8. PubMed ID: 8393884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: interaction with endogenous opioid peptides.
    Inder WJ; Joyce PR; Ellis MJ; Evans MJ; Livesey JH; Donald RA
    Clin Endocrinol (Oxf); 1995 Sep; 43(3):283-90. PubMed ID: 7586596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of naloxone on oxytocin-induced cortisol decrease in normal men.
    Coiro V; Chiodera P; Rossi G; Volpi R; Salvi M; Camellini L; Roti E
    Acta Endocrinol (Copenh); 1985 Feb; 108(2):261-5. PubMed ID: 2982243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics of naloxone-precipitated withdrawal in human opioid-dependent subjects.
    Kanof PD; Handelsman L; Aronson MJ; Ness R; Cochrane KJ; Rubinstein KJ
    J Pharmacol Exp Ther; 1992 Jan; 260(1):355-63. PubMed ID: 1731046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortisol and adrenocorticotropic hormone responses to naloxone in subjects with high and low neuroticism.
    Mangold DL; Wand GS
    Biol Psychiatry; 2006 Oct; 60(8):850-5. PubMed ID: 16950229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of a disturbance of the hypothalamic-pituitary-adrenal axis in polycystic ovary syndrome: effect of naloxone.
    Lanzone A; Guido M; Ciampelli M; Fulghesu AM; Pavone V; Proto C; Caruso A; Mancuso S
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):73-7. PubMed ID: 8796141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, placebo-controlled crossover study of the effects of levetiracetam on cognition, mood, and balance in healthy older adults.
    Schoenberg MR; Rum RS; Osborn KE; Werz MA
    Epilepsia; 2017 Sep; 58(9):1566-1574. PubMed ID: 28731266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alprazolam blocks the naloxone-stimulated hypothalamo-pituitary-adrenal axis in man.
    Torpy DJ; Grice JE; Hockings GI; Walters MM; Crosbie GV; Jackson RV
    J Clin Endocrinol Metab; 1993 Feb; 76(2):388-91. PubMed ID: 8381800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose naloxone in older normal subjects: implications for Alzheimer's disease.
    Tariot PN; Gross M; Sunderland T; Cohen MR; Weingartner H; Murphy DL; Cohen RM
    J Am Geriatr Soc; 1988 Aug; 36(8):681-6. PubMed ID: 3042841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of creatine supplementation and sleep deprivation, with mild exercise, on cognitive and psychomotor performance, mood state, and plasma concentrations of catecholamines and cortisol.
    McMorris T; Harris RC; Swain J; Corbett J; Collard K; Dyson RJ; Dye L; Hodgson C; Draper N
    Psychopharmacology (Berl); 2006 Mar; 185(1):93-103. PubMed ID: 16416332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of elevated triiodothyronine on cognitive performance and mood in healthy subjects.
    Kathmann N; Kuisle U; Bommer M; Naber D; Müller OA; Engel RR
    Neuropsychobiology; 1994; 29(3):136-42. PubMed ID: 8022533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.